162.01k followers • 18 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit over £43 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalisation of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the US is projected to hit £17.8 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.How do we pick these stocks?
This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.How are these weighted?
The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|ABBV||AbbVie Inc.||138.32||+4.11||+3.06%||4:03 pm GMT-4||6.66M||5.51M||244.56B|
|BUD||Anheuser-Busch InBev SA/NV||45.85||+0.69||+1.53%||4:00 pm GMT-4||1.62M||1.39M||90.59B|
|MO||Altria Group, Inc.||41.37||+0.99||+2.45%||4:03 pm GMT-4||8.57M||8.36M||74.50B|
|TAP||Molson Coors Beverage Company||48.58||+0.59||+1.23%||4:04 pm GMT-4||1.05M||1.45M||10.56B|
|SMG||The Scotts Miracle-Gro Company||43.73||+0.98||+2.29%||4:00 pm GMT-4||1.44M||624.25k||2.42B|
|WEED.TO||Canopy Growth Corporation||3.94||+0.19||+5.07%||3:59 pm GMT-4||1.65M||2.70M||1.89B|
|TLRY||Tilray Brands, Inc.||2.87||+0.12||+4.36%||4:00 pm GMT-4||14.58M||24.78M||1.69B|
|CGC||Canopy Growth Corporation||2.91||+0.18||+6.59%||4:00 pm GMT-4||6.96M||11.84M||1.40B|
|CRON||Cronos Group Inc.||2.93||+0.11||+3.90%||4:00 pm GMT-4||1.11M||1.91M||1.11B|
|ACB||Aurora Cannabis Inc.||1.23||+0.01||+0.82%||4:00 pm GMT-4||6.12M||9.74M||368.80M|
|TGODF||The Green Organic Dutchman Holdings Ltd.||0.03882||+0.00||+0.05%||3:46 pm GMT-4||197.75k||353.77k||30.31M|
|CRBP||Corbus Pharmaceuticals Holdings, Inc.||0.1681||+0.00||+1.88%||4:00 pm GMT-4||710.03k||951.40k||21.06M|
|CANN||Trees Corporation||0.202||+0.01||+6.32%||3:58 pm GMT-4||41.98k||49.25k||19.43M|
|NBEV||NewAge, Inc.||0.0935||-||-||4:00 pm GMT-4||47.16M||10.83M||13.73M|
|MJ||ETFMG Alternative Harvest ETF||4.79||+0.20||+4.36%||4:00 pm GMT-4||758.85k||1.32M||-|
Based on Monday's view of an IBD-produced screen, they now include small-cap enterprise software firm Model N, lithium metal producer Albemarle, electrical equipment firm Hubbell and trendy footwear and apparel firm Deckers Outdoor. In 2022, the NYSE's composite index continues to outperform its Nasdaq sibling. Since the November 2021 peak in the market, the NYSE composite has fallen as much as 20% from its 17,442 peak.
FEMSA (FMX) looks poised for growth on its diversified business portfolio, growth in digital business and expansion in the specialized distribution business.
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.